期刊文献+

亚砷酸、维甲酸联合去甲氧柔红霉素治疗急性早幼粒细胞白血病效果观察 被引量:4

原文传递
导出
摘要 目的 观察全反式维甲酸和亚砷酸双诱导联合去甲氧柔红霉素(商品名:伊达比星)治疗急性早幼粒细胞白血病(APL)的效果.方法 将住院诊治的42例APL患者按随机数表抽取样本方法分为治疗组和对照组.治疗组22例,诱导缓解治疗方案为,维甲酸60 mg/d,亚砷酸10ml/d,去甲氧柔红霉素每天10mg/m2,第1天至第3天;对照组20例,治疗方案为亚砷酸10ml/d,维甲酸60mg/d,柔红霉素每天45 mg/m2,第1天至第3天.结果 治疗组初治诱导完全缓解率为95.45%(21/22),高于对照组的85.00%(17/20)(P<0.05),治疗组达完全缓解中位时间为26 d,高于对照组的34 d,差异有统计学意义(P<0.05).治疗组治疗相关不良反应与对照组比较差异无统计学意义(P>0.05).结论 亚砷酸、维甲酸联合去甲氧柔红霉素治疗APL效果好,安全性高.
出处 《白血病.淋巴瘤》 CAS 2015年第5期307-308,320,共3页 Journal of Leukemia & Lymphoma
  • 相关文献

参考文献8

  • 1Daver N, Kantarjian H, Marcucci G, et al. Clinical characteristics and outcomes in patients with acute promyelocytic leukaemia and hyperleu- cocytosis [ J ]. Br J Haematol, 2014, 168 ( 5 ) : 646-653.
  • 2张之南,沈悌.白血病诊断及疗效标准[M].2版.北京:科学出版社,1998:171.
  • 3Stein EM, Tallman MS. Acute promyelocytic leukemia in children and adolescents [ J ]. Acta Haematol, 2014, 132 ( 3-4 ) : 307-312.
  • 4Cabral R, Caballero JC, Alonso S, et al. Late differentiation syndrome in acute promyelocytic leukemia: a challenging diagnosis [ J ]. nematol Rep, 2014,6 ( 4 ) : 5654.
  • 5Kitamura K, Kiyoi H, Yoshida H, et al. New retinoids an arsenic compounds for the treatment of refractory acute promyelocytic leukemia: clinical and basic studies for the next generation [ J ]. Cancer Chemother Pharmacol, 1997, 40 ( Suppl ) : $36-41.
  • 6Shen ZX, Shi ZZ, Fang J, et al. All-trans retinoic acid / As203 combination yields a high quality remission and survival in newly diagnosed acute promyelocytic leukemia [ J ]. Proc Natl Aead Sci USA, 2004, 101 ( 15 ) : 5328-5335.
  • 7Ades L, Chevret S, Raffoux E, et al. Is cytarabine useful in the treatment of acute promyelocytic leukemia? results of a randomized trial from the European acute promyelocytic leukemia Group [ J ]. J Clin Oncol, 2006, 24 ( 36 ) : 5703-5710.
  • 8白萍萍,张茵,马保根,袁晓莉,时杰,陈玉清.三氧化二砷联合全反式维甲酸治疗初发急性早幼粒细胞白血病的临床观察[J].白血病.淋巴瘤,2011,20(5):278-281. 被引量:8

二级参考文献21

  • 1欧阳仁荣,孙关林.全反式维甲酸诱导分化治疗急性早幼粒细胞白血病五年研究总结[J].中华肿瘤杂志,1993,15(2):125-129. 被引量:14
  • 2Lo Coco F, Diverio D, Falini B, et al. Genetic diagnosis and molecular monitoring in the management of acute promyelocytic leukemia. Blood, 1999, 94: 12-22.
  • 3Wang ZY, Chen Z. Acute promyelocytie leukemia: from highly fatal to highly curable. Blood, 2008, 111 : 2505-2515.
  • 4Fenanx P, Chomienne C, Degos L. All-trans retinoic acid and chemotherapy in the treatment of acute promyelocytic leukemia. Seminars Hematol, 2001,38:13.
  • 5Mathews V, George B, Lakshmi KM, et al. Single-agent arsenic trioxide in the treatment of newly diagnosed acute promyelocytic leukemia: durable remissions with minimal toxicity. Blood, 2006, 107: 2627-2632.
  • 6Shen ZX, Shi ZZ, Fang J, et al. All-trans retinoie acid/As203 combination yields a high quality remission and survival in newly diagnosed acute promyeloeytie leukemia. Proc Natl Acad Sci U S A, 2004, 101: 5328-5335.
  • 7Sanz MA, Lo Coco F, Martin G, et al Definition of relapse risk and role ofnonanthracycline drugs fou consolidation in Patients with acute promyelocytic leukemia:a joint study of the PETHEMA and GMEMA cooperative groups. Blood, 2000, 96: 1247-1253.
  • 8Michieli M, Damiani D, Ermaeora A, et al. P-glyco protein, lung resistance-related protein and multidrug resistance-associated protein expression in acute promyelocytic leukemia. Br J Haematol, 2000, 108: 703-709.
  • 9Frankel SR, Eardley A, Lauwers G, et al. The "retinoic acid syndrome" in acute promyelocytic leukemia. Ann Intern Med, 1992, 117: 292-296.
  • 10de Botton S, Dowbret H, Sanz M, et al. Incidence,clinical features and outcome of all trans retinoic acid syndrome in 413 cases of newly diagnosed acute promyelocytic leukemia. Blood, 1998, 92: 2712- 2718.

共引文献7

同被引文献32

引证文献4

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部